Medication adherence program: Adherence challenges and interventions in type 2 diabetes

被引:31
作者
Odegard, Peggy Soule [1 ]
Carpinito, Gina [1 ]
Christensen, Dale B. [1 ]
机构
[1] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
关键词
Adherence (medication); diabetes; interventions; community pharmacy; PHARMACOTHERAPY; MELLITUS; COHORT; ADULTS;
D O I
10.1331/JAPhA.2013.12065
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To describe medication adherence problems for adults with type 2 diabetes and to assess the nature and frequency of pharmacist activities in addressing them and proximate outcomes. Design: Pre-post analysis. Setting: Four community chain pharmacies located in Seattle, WA, from April 2008 to October 2009. Patients: 120 patients (mean age >60 years) with type 2 diabetes taking oral diabetes medications and who were 6 or more days late for refills. Intervention: Pharmacist telephone-initiated adherence support. Main outcomes measures: Nature and frequency of adherence-related problems and intervention activities and impact on reduction in refill gaps. Results: The primary adherence challenge was difficulty taking medications (27.1%). Failure to remember doses and forgetting refills were reported by 24.6% and 26.3% of patients at baseline, respectively. Pharmacists provided support through some form of patient education (35.6% of encounters) or other adherence support (40.7%). Pharmacist time averaged slightly greater than 5 minutes per intervention and 12.6 +/- 10.7 minutes (mean +/- SD) over 12 months, with 3.4 +/- 2.4 interventions per patient. Patient-specific education and adherence support by pharmacists and total intervention time were positively correlated, with a modest but significant reduction in refill gaps during 12 months of follow-up. Conclusion: Not remembering to refill medications was the most commonly reported problem. Patient encounters averaged 4 to 6 minutes for the first visit and 12 to 13 minutes over 12 months. Phone calls by pharmacists to adults who were late for oral diabetes medication refills were effective in identifying adherence-related problems and developing support strategies to promote medication self-management in busy urban community chain pharmacy settings.
引用
收藏
页码:267 / U47
页数:7
相关论文
共 50 条
  • [21] Race and medication adherence in Medicaid enrollees with type-2 diabetes
    Shenolikar, Rahul A.
    Balkrishnan, Rajesh
    Camacho, Fabian T.
    Whitmire, J. Timothy
    Anderson, Roger T.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (07) : 1071 - 1077
  • [22] Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study
    Rezaei, Mehdi
    Valiee, Sina
    Tahan, Mohammad
    Ebtekar, Fariba
    Gheshlagh, Reza Ghanei
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 589 - 599
  • [23] Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes
    Reach, G.
    Pellan, M.
    Crine, A.
    Touboul, C.
    Ciocca, A.
    Djoudi, Y.
    DIABETES & METABOLISM, 2018, 44 (06) : 500 - 507
  • [24] Psychosocial predictors of medication adherence among patients with type 2 diabetes
    Moral de la Rubia, Jose
    Alejandra Cerda, Maria Teresa
    REVISTA IBEROAMERICANA DE PSICOLOGIA Y SALUD, 2015, 6 (01): : 19 - 27
  • [25] Empowerment, motivation, and medical adherence (EMMA): the feasibility of a program for patient-centered consultations to support medication adherence and blood glucose control in adults with type 2 diabetes
    Varming, Annemarie Reinhardt
    Hansen, Ulla Moller
    Andresdottir, Gudbjorg
    Husted, Gitte Reventlov
    Willaing, Ingrid
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1243 - 1253
  • [26] Profiling of patients with type 2 diabetes based on medication adherence data
    Markovic, Rene
    Grubelnik, Vladimir
    Zavrsnik, Tadej
    Blazun Vosner, Helena
    Kokol, Peter
    Perc, Matjaz
    Marhl, Marko
    Zavrsnik, Matej
    Zavrsnik, Jernej
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [27] Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes
    Egede, Leonard E.
    Gebregziabher, Mulugeta
    Hunt, Kelly J.
    Axon, Robert N.
    Echols, Carrae
    Gilbert, Gregory E.
    Mauldin, Patrick D.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (02) : 169 - 178
  • [28] Type 2 diabetes and kidney transplant: comparative study on medication adherence
    de Oliveira Procopio, Fernanda
    Rangel, Erika Bevilaqua
    de Aguiar Roza, Bartira
    de Sa, Joao Roberto
    Schirmer, Janine
    ACTA PAULISTA DE ENFERMAGEM, 2023, 36
  • [29] Medication Adherence Affects Treatment Modifications in Patients With Type 2 Diabetes
    Voorham, Jaco
    Haaijer-Ruskamp, Flora M.
    Wolffenbuttel, Bruce H. R.
    Stolk, Ronald P.
    Denig, Petra
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 121 - 134
  • [30] Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes
    Venditti, E. M.
    Tan, K.
    Chang, N.
    Laffel, L.
    McGinley, G.
    Miranda, N.
    Tryggestad, J. B.
    Walders-Abramson, N.
    Yasuda, P.
    Delahanty, L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 139 : 24 - 31